Piessevaux H, De Winter B, Louis E, Muls V, De Looze D, Pelckmans P. Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil., 2009;21:378-388.

Tack J, Talley NJ, Camilleri M. et al. Functional gastroduodenal disorders. Gastroenterology, 2006;130 (5): 1466-1479.

Oshima T, Toyoshima F, Nakajima S, Fukui H, Watari J, Miwa H. Genetic factors for functional dyspepsia.J Gastroenterol Hepatol., 2011;26(3):83-87.

Richter J. Stress and psychological and environmental factors in functional dyspepsia. Scand. J. Gastroenterol. 1991;26(182):40-46.

Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology. 2004;127:1239-55.

Brun R, Kuo B. Functional dyspepsia. Ther Adv Gastroenterol, 2010;3(3):145-164.

Шептулин А.А. Хронический гастрит и функциональная диспепсия: существует ли выход из тупика? Эффективная Фармакотерапия, 2012;1:59-61.

Haag S, Talley NJ, Holtmann G. Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters. Gut, 2004;53:1445-1451.

Zai H, Kusano M. Investigation of gastric emptying disorders in patients with functional dyspepsia reveals impaired inhibitory gastric emptying regulation in the early postcibal period. Digestion, 2009;79(1):13-18.

Kindt S, Dubois D, Van Oudenhove L, Caenepeel P, Arts J, Bisschops R. Relationship between symptom pattern, assessed by the PAGI-SYM © questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia. Neurogastroenterol Motil., 2009;21:1183-e105.

Материалы консультативного совета по вопросам функциональной диспепсии и препарату Ганатон. Азиатско-Тихоокеанский регион. Тайланд, Чанг. Май, 2010.

Malfertheiner P, Megraud F, O’Morain C. et al. Management of Helicobacter pylori infection: the Maastricht IV/ Florence Consensus Report. Gut, 2012;61:646-664.

Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev, 2006: CD001960.

Moayyedi P, Soo S, Deeks J, Forman D, Harris A, Innes M. Systematic review: antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther., 2003;17:1215-1227.

Karamanolis G, Tack J. Promotility medications-now and in the future. Dig.Dis.,2006;24:297-307.

Sifirim D. Disorders of gastric emptying. Innovations in assessing gastric emptying and new pharmacology in the foregut. Workshop. 9th World Congress OESO. Monaco, 2008.

Holtmann G, Talley NJ, Liebregts T. et al. A placebo-controlled trial of itopride in functional dyspepsia. N. Engl. J. Med., 2006;354:832-840.

Ghosh A, Halder S, Mandal S. et al. Rabeto plus: a valuable drug for managing functional dyspepsia. J Indian Med Assoc., 2008;106:752-754.

Булгаков С.А. Возможности применения Oмеза Д в лечении функциональной диспепсии. Фарматека, 2010;20:39-42.

Пасечников В.Д., Пасечников Д.В. Оценка эффективности терапии функциональной диспепсии фиксированной комбинацией ингибитора протонной помпы (омепразол) и прокинетика (домперидон). Фарматека, 2011;20:77-81.